Europe - Frankfurt Stock Exchange - FRA:BNR - DE000A1DAHH0 - Common Stock
The current stock price of BNR.DE is 49.59 EUR. In the past month the price increased by 2.11%. In the past year, price decreased by -18.93%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| RXL.PA | REXEL SA | 29.02 | 9.81B | ||
| INX.DE | IMCD NV | 17.27 | 4.67B | ||
| IMCD.AS | IMCD NV | 16.87 | 4.57B | ||
| AZE.BR | AZELIS GROUP NV | 13.43 | 2.26B | ||
| THEP.PA | THERMADOR GROUPE | 17.45 | 693.68M | ||
| KCO.DE | KLOECKNER & CO SE | 2.61 | 603.99M | ||
| JCQ.PA | JACQUET METALS SA | 31.48 | 379.57M | ||
| HMU.DE | HMS BERGBAU AG | 17.8 | 240.97M | ||
| WOLF.DE | META WOLF AG | 27.69 | 89.68M | ||
| ALHRG.PA | HERIGE | 5.59 | 63.69M | ||
| ABLD.PA | ABL DIAGNOSTICS | 102.67 | 49.62M | ||
| ALUPG.PA | UPERGY | 216 | 10.22M |
Brenntag SE engages in the provision of production and distribution of chemicals. The company is headquartered in Essen, Nordrhein-Westfalen and currently employs 18,100 full-time employees. The company went IPO on 2010-03-29. The firm offers a broad product range comprising more than 20,000 chemicals and ingredients as well as services such as just-in-time delivery, product mixing, repackaging, inventory management and drum return handling. The company also offers tailor-made application, marketing and supply chain solutions, technical and formulation support, comprehensive regulatory know-how and digital solutions such as digital sales channels and product platforms. The firm manages its business through two global divisions: Brenntag Specialties focuses on selling ingredients and value-added services, and it focuses on industries Nutrition, Pharma, Personal Care/Home, Industrial & Institutional, Material Science (Coatings & Construction, Polymers, Rubber), Water Treatment and Lubricants. Brenntag Essentials markets a broad portfolio of process chemicals across a wide range of industries and applications.
BRENNTAG SE
Messeallee 11
Essen NORDRHEIN-WESTFALEN DE
Employees: 18122
Phone: 4920164960
Brenntag SE engages in the provision of production and distribution of chemicals. The company is headquartered in Essen, Nordrhein-Westfalen and currently employs 18,100 full-time employees. The company went IPO on 2010-03-29. The firm offers a broad product range comprising more than 20,000 chemicals and ingredients as well as services such as just-in-time delivery, product mixing, repackaging, inventory management and drum return handling. The company also offers tailor-made application, marketing and supply chain solutions, technical and formulation support, comprehensive regulatory know-how and digital solutions such as digital sales channels and product platforms. The firm manages its business through two global divisions: Brenntag Specialties focuses on selling ingredients and value-added services, and it focuses on industries Nutrition, Pharma, Personal Care/Home, Industrial & Institutional, Material Science (Coatings & Construction, Polymers, Rubber), Water Treatment and Lubricants. Brenntag Essentials markets a broad portfolio of process chemicals across a wide range of industries and applications.
The current stock price of BNR.DE is 49.59 EUR. The price increased by 0.28% in the last trading session.
BRENNTAG SE (BNR.DE) has a dividend yield of 4.39%. The yearly dividend amount is currently 2.08.
BNR.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The PE ratio for BRENNTAG SE (BNR.DE) is 17.1. This is based on the reported non-GAAP earnings per share of 2.9 and the current share price of 49.59 EUR.
BRENNTAG SE (BNR.DE) has a market capitalization of 7.16B EUR. This makes BNR.DE a Mid Cap stock.
ChartMill assigns a technical rating of 1 / 10 to BNR.DE. When comparing the yearly performance of all stocks, BNR.DE is a bad performer in the overall market: 87.35% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to BNR.DE. BNR.DE has an excellent profitability rating, but there are some minor concerns on its financial health.
Over the last trailing twelve months BNR.DE reported a non-GAAP Earnings per Share(EPS) of 2.9. The EPS decreased by -22.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.64% | ||
| ROA | 3.92% | ||
| ROE | 10.04% | ||
| Debt/Equity | 0.62 |
24 analysts have analysed BNR.DE and the average price target is 57.84 EUR. This implies a price increase of 16.64% is expected in the next year compared to the current price of 49.59.
For the next year, analysts expect an EPS growth of -15.76% and a revenue growth -4.03% for BNR.DE